In Brief: FDA budget
This article was originally published in The Gray Sheet
FDA budget: Fiscal year 1999 budget proposal for FDA and other federal agencies slated for release Feb. 2. Like last year's proposal, the FY 1999 budget is expected to call for device user fees for deficit reduction. Hearings on FDA's budget are slated for Feb. 12 and March 31 by House and Senate Appropriations subcommittees, respectively. FDA is in ongoing discussions with the subcommittees over its fiscal 1998 operating plan. The agency recently delivered a revised plan after the first one was rejected as too general ("The Gray Sheet" Jan. 19, p. 9)...
You may also be interested in...
The WHO’s new "living guideline" against remdesivir’s use in hospitalized patients notwithstanding, some key opinion leaders in India see a role for the antiviral, but underscore that COVID-19 is still in its infancy and all repurposed therapies for the disease still have a long way to go. They also see the US remdesivir studies as more robust.
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things.
A recent Department of Health and Human Services proposal to review regulations every 10 years may mean good things for the device industry, said David Hoffmeister, partner, Wilson Sonsini Goodrich & Rosati.